News

Positive Phase III data for migraine drug Fremanezumab

Positive results from a Phase III HALO study of fremanezumab, an anti-calcitonin gene-related peptide (CGRP) monoclonal antibody investigational treatment for the prevention of migraine, have been announced by Israel-based Teva Pharmaceutical Industries (NYSE: TEVA). In the chronic migraine (CM) study, patients treated with fremanezumab experienced statistically-significant reduction in the number of monthly headache days of

Positive Phase III data for migraine drug Fremanezumab Read More »

Under the hat

The European Headache Federation (EHF) and the European Migraine Headache Alliance (EMHA) are pleased to announce the 21st March as the first Cluster Headache Day as part of the ‘What’s the Under the Hat?’ public awareness campaign. Cluster headache is one of the worst pains known to man and affects up to 4 in 1,000

Under the hat Read More »

The results of greater occipital nerve block applied for migraine headache

OBJECTIVES: The aim of this study was to evaluate the efficacy of greater occipital nerve (GON) block in the treatment of migraine patients. METHODS: This study included 28 patients diagnosed with migraine between 2014 and 2015. The GON block procedure was applied by administering 1.5 ml of 2% lidocaine 2 cm lateral and 2 cm

The results of greater occipital nerve block applied for migraine headache Read More »

Disability & Catastrophizing In Chronic Migraine vs Temporomandibular Disorder

Patients with chronic migraine share features with individuals with temporomandibular disorders that include kinesiophobia and neck disability, according to a cross-sectional study recently published in Pain Medicine.1 A growing body of research indicates a number of shared features between chronic migraine and TMD. For example, patients with chronic migraine, but not headache-free individuals, commonly experience

Disability & Catastrophizing In Chronic Migraine vs Temporomandibular Disorder Read More »

Road trip 2017- Migraine Association of Ireland

The Migraine Association of Ireland is going on a ‘road-trip’! In October of 2017 they will be traveling the country to locations they seldom get the chance to visit and holding information stands in various places. So keep an eye out for them if you live in the following counties; Galway, Mayo, Sligo, Waterford, Wexford, Carlow, Kilkenny,  They will be

Road trip 2017- Migraine Association of Ireland Read More »

Scroll to Top
Search
Close this search box.